These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21457725)

  • 21. Promotion of cervical screening among nonattendees: a partial cost-effectiveness analysis.
    Oscarsson MG; Benzein EG; Wijma BE; Carlsson PG
    Eur J Cancer Prev; 2007 Dec; 16(6):559-63. PubMed ID: 18090130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.
    Lisi D; Hassan C; Crespi M;
    Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer.
    Eaker S; Adami HO; Granath F; Wilander E; Sparén P
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening.
    Lee JK; Groessl EJ; Ganiats TG; Ho SB
    BMC Gastroenterol; 2011 Aug; 11():93. PubMed ID: 21867492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
    Kiran T; Davie S; Moineddin R; Lofters A
    J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
    Shankaran V; McKoy JM; Dandade N; Nonzee N; Tigue CA; Bennett CL; Denberg TD
    J Clin Oncol; 2007 Nov; 25(33):5248-53. PubMed ID: 18024871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-visit-based cancer screening using a novel population management system.
    Atlas SJ; Zai AH; Ashburner JM; Chang Y; Percac-Lima S; Levy DE; Chueh HC; Grant RW
    J Am Board Fam Med; 2014; 27(4):474-85. PubMed ID: 25002002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening.
    Ling BS; Schoen RE; Trauth JM; Wahed AS; Eury T; Simak DM; Solano FX; Weissfeld JL
    Arch Intern Med; 2009 Jan; 169(1):47-55. PubMed ID: 19139323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
    de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
    Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of patient reminder letters to promote cancer screening services in women: A population-based study in Wisconsin.
    Reeves MJ; Remington PL
    Prev Med; 1999 Sep; 29(3):202-9. PubMed ID: 10479608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
    Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
    Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005.
    Trivers KF; Shaw KM; Sabatino SA; Shapiro JA; Coates RJ
    Am J Prev Med; 2008 Sep; 35(3):185-93. PubMed ID: 18617355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a randomized controlled trial to increase colorectal cancer screening in a managed care health plan.
    Ganz PA; Farmer MM; Belman MJ; Garcia CA; Streja L; Dietrich AJ; Winchell C; Bastani R; Kahn KL
    Cancer; 2005 Nov; 104(10):2072-83. PubMed ID: 16216030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.